Uploaded bySeemaGosavi3
PPTX, PDF297 views

Validation Master Plan (VMP) in Pharmaceutical.pptx

An overview of the Validation Master Plan – a key document in ensuring GMP compliance.

Embed presentation

Download to read offline
Validation Master Plan (VMP) in Pharmaceutical Industry AN OVERVIEW OF THE VALIDATION MASTER PLAN – A KEY DOCUMENT IN ENSURING GMP COMPLIANCE. Dr Seema A Gosavi Associate Professor Department of Pharmaceutical Chemistry Sanjivani College of Pharmaceutical Education and Research, Kopargaon E-mail: seemagosavibpharm@sanjivani.org.in Mobile: 9860077084
Learning Objectives: • Understand the concept and importance of the Validation Master Plan (VMP). • Identify the key components, roles, and responsibilities associated with a VMP. • Explain the validation lifecycle and associated documentation. • Recognize the regulatory requirements and compliance aspects.
Learning Outcomes:  Students will be able to define and describe the purpose of a VMP.  Students will identify and explain various types of validation (equipment, process, cleaning, etc.).  Students will interpret the structure of a VMP and list key regulatory references.  Students will evaluate the impact of validation failures and propose mitigation strategies.
Introduction  Validation is a fundamental requirement in pharmaceutical manufacturing.  Ensures consistent quality, safety, and efficacy of products.  VMP is the backbone of validation activities. Definition: A Validation Master Plan (VMP) is a comprehensive document that outlines the overall strategy and approach for validation activities within a pharmaceutical manufacturing facility. It serves as a roadmap for ensuring that all processes, equipment, and systems meet predetermined quality standards and regulatory requirements.
What is a Validation Master Plan? • A high-level document describing the company’s approach to validation. • Defines the scope, strategy, and responsibilities. • Covers facilities, systems, equipment, and processes.
Purpose of VMP • Ensure product quality and regulatory compliance • Provide structured validation activities • Demonstrate GMP adherence • To provide a framework for all validation activities. • To define responsibilities, timelines, and scope of validation. • To ensure compliance with regulatory guidelines (e.g., FDA, EMA, WHO, PIC/S). • To ensure product quality, safety, and efficacy through validated processes. • To coordinate validation efforts and avoid duplication.
Scope of the VMP Includes Facilities, Utilities, Equipment, Cleaning, Computer Systems, And Analytical Methods That Affect Product Quality. • Defines which systems, equipment, processes, and utilities are covered. • May include production, packaging, cleaning, utilities, computerized systems, etc. • Manufacturing processes • Facilities and utilities • Equipment and software systems • Cleaning and analytical methods
Regulatory Expectations • WHO TRS 937 • EU GMP Annex 15 • US FDA guidelines • ICH Q8, Q9, Q10 Regulatory Body Key Document / Regulation VMP Requirement Highlight FDA 21 CFR Parts 210 & 211 Written validation procedures; validation plan FDA Process Validation Guidance (2011) Risk-based validation strategy & documentation EMA EU GMP Annex 15 Validation Master Plan mandatory; detailed scope and strategy PIC/S PIC/S Guide Annex 15 VMP content, roles, responsibilities, change control WHO WHO GMP Guidelines Validation plan for critical processes/systems
Key Components of VMP Component Description 1. Introduction Overview of the facility, manufacturing processes, and purpose of the VMP. 2. Scope Defines which systems, processes, equipment, and utilities are covered under the VMP. 3. Validation Policy Company’s overall approach and commitment to validation, aligned with regulatory requirements. 4. Organizational Structure and Responsibilities Roles and responsibilities of the validation team and involved departments (QA, Production, etc.). 5. Validation Strategy Description of validation types (process, equipment, cleaning, computerized systems) and risk-based approach. 6. Validation Lifecycle and Documentation Stages of validation (DQ, IQ, OQ, PQ), protocol and report requirements, documentation control. 7. Schedule and Timeline Timeline and prioritization for validation activities, including project milestones. 8. Change Control Procedures for managing changes impacting validated systems and when revalidation is necessary. 9. Training Training requirements and plans for personnel involved in validation activities. 10. Deviation and CAPA Management Handling deviations during validation and implementing corrective/preventive actions. 11. References List of regulatory guidelines, SOPs, and standards referenced in the VMP.
Structure of a VMP Document  Introduction and validation policy  Organizational responsibilities  Validation strategy and schedule  Documentation and reporting
Validation Policy Definition: The Validation Policy is a formal statement that outlines the company’s commitment and approach to validation. It sets the foundation for all validation activities and ensures alignment with regulatory requirements and industry best practices. Purpose of the Validation Policy: • To establish a clear and consistent approach to validation across the organization. • To ensure that all processes, equipment, systems, and methods affecting product quality are validated. • To comply with regulatory expectations and good manufacturing practices (GMP). • To support product quality, safety, and efficacy through effective validation.
Roles and Responsibilities •Quality Assurance: Oversight and approvals •Engineering: Equipment validation •Manufacturing: Process knowledge and SOP adherence Role Responsibilities Validation Manager - Develops and maintains the VMP - Oversees all validation activities - Approves protocols/reports Quality Assurance (QA) - Reviews/approves VMP, protocols, and reports - Ensures compliance with GxP and regulatory guidelines - Manages deviations and CAPAs Validation Engineer - Drafts and executes validation protocols (IQ, OQ, PQ) - Records results - Investigates deviations Process Owner / Dept. Head - Provides technical input for validation - Ensures validated systems are used properly - Supports re-validation efforts Engineering / Maintenance - Installs/calibrates equipment - Provides technical documentation - Supports validation and change control Regulatory Affairs - Ensures validation aligns with regulations - Supports inspections and submissions with validation data IT / CSV Team - Validates computerized systems - Ensures 21 CFR Part 11 and data integrity compliance - Maintains system validation
Validation Lifecycle Design Qualification (DQ), Installation Qualification (IQ) , Operational Qualification (OQ), Performance Qualification (PQ) Phase Objective Key Deliverables / Activities 1. Planning Define scope, responsibilities, and strategy for validation - Validation Master Plan (VMP) - Risk Assessment - Project Plan 2. Design Qualification (DQ) Verify design meets intended purpose and regulatory requirements - User Requirements Specification (URS) - Functional/Design Specs - DQ Report 3. Installation Qualification (IQ) Verify equipment/system is installed correctly and per specifications - IQ Protocol - Calibration & Utility Verification - IQ Report 4. Operational Qualification (OQ) Verify the system operates as intended under all conditions - OQ Protocol - Test Scripts - Alarm/Function Testing - OQ Report 5. Performance Qualification (PQ) Verify the system performs consistently in real-world scenarios - PQ Protocol - Batch/Process Testing - PQ Report 6. Validation Report / Summary Summarize results and determine validation acceptance - Validation Summary Report - Deviations & CAPAs addressed 7. Maintenance / Revalidation Maintain validated state and manage changes over time - Change Control - Periodic Review - Revalidation Plan 8. Decommissioning (if applicable) Ensure proper retirement of systems while maintaining data integrity - Decommissioning Plan - Data Archival - Final Validation Status
Facility and Equipment Validation Ensures that the facility and equipment operate as intended and meet GMP standards. Section Details Equipment/Facility Name (Enter the specific equipment or area being validated) Equipment/Facility ID (Asset tag, serial number, or internal ID) Location (Room number, department, site) Manufacturer / Model (Equipment manufacturer and model) Validation Type ☐ New Installation Re-Validation Periodic Review ☐ ☐ Validation Dates Start: __________ End: __________ Validation Protocols Executed ☐ DQ IQ OQ PQ ☐ ☐ ☐ Key Test Parameters (List critical parameters such as temperature, pressure, airflow, etc.) Acceptance Criteria (Specify the acceptance criteria for each test stage) Deviations Noted (Summarize any deviations and their resolution) Validation Status ☐ Passed Failed Pending Review ☐ ☐ Responsible Person (Name and designation of the person responsible for validation) Reviewed By (QA) (Name, signature, and date) Approval Validation Manager Signature: ____________ Date: ____________
Process Validation Definition of Process Validation “Process Validation is the collection and evaluation of data, from the process design stage through commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality product.” — FDA Guidance for Industry Type Description 1. Prospective Validation Conducted before the product is released; most common for new processes. 2. Concurrent Validation Conducted during actual production of commercial batches (e.g., urgent cases). 3. Retrospective Validation Based on historical data of already marketed products (rarely used now). 4. Revalidation Repeated validation due to changes in process, equipment, facility, etc.
In a Validation Master Plan (VMP), process validation is a core section that outlines the strategy, scope, and responsibilities for validating pharmaceutical manufacturing processes. It provides a high- level roadmap to ensure consistent product quality and compliance with regulatory requirements (e.g., FDA, EMA, WHO, ICH Q8-Q10). Purpose of Including Process Validation in VMP  Ensure all critical processes are validated before commercial production.  Establish a standardized approach for process qualification.  Meet regulatory expectations for lifecycle validation.  Provide traceability and control across all stages of validation. Process Validation
Key Elements of Process Validation in a VMP Section Content Description Objective Define the purpose of process validation and its role in assuring product quality. Scope Covers all manufacturing processes, including critical steps and control strategies. Regulatory References ICH Q8-Q10, FDA Guidance (2011), EU Annex 15, WHO TRS, etc. Validation Approach Lifecycle-based approach (Process Design, Qualification, Continued Verification). Types of Validation Prospective, Concurrent, Retrospective (if justified), and Revalidation. Process Qualification Strategy Outline how many batches will be validated, sampling plan, and statistical justification. Roles and Responsibilities QA, Production, Validation team, Engineering—clearly defined in a RACI matrix. Documentation Process validation protocols, reports, batch records, deviations, CAPAs. Change Control Criteria for revalidation in case of process changes. Risk Assessment Application of Quality Risk Management (QRM) to determine validation scope and depth. Continued Process Verification Plan for ongoing monitoring (e.g., trending, statistical process control).
Establishes documented evidence that cleaning procedures remove residues to an acceptable level. Cleaning Validation in the Validation Master Plan (VMP) Cleaning Validation is a crucial section of the Validation Master Plan (VMP) in pharmaceutical manufacturing. It ensures that cleaning procedures effectively remove product residues, cleaning agents, and contaminants from equipment to prevent cross- contamination and ensure product quality. Purpose of Cleaning Validation in the VMP •Demonstrate that cleaning processes consistently meet predefined acceptance criteria. •Ensure compliance with regulatory requirements (FDA, EU GMP, WHO, PIC/S). •Prevent cross-contamination and ensure patient safety.
Key Elements of Cleaning Validation in the VMP Section Content Objective Define the purpose of cleaning validation within the overall validation strategy. Scope Identify which equipment, products, and cleaning procedures are covered. Regulatory References FDA 21 CFR Part 211, EU Annex 15, WHO TRS 937, PIC/S PI 006, ICH Q9. Cleaning Strategies - Product-specific vs. campaign-based cleaning - Manual vs. automated (CIP/SIP) methods Worst-Case Selection Justification of worst-case product/equipment for validation studies. Acceptance Criteria - Residue limits (MACO – Maximum Allowable Carry Over) - Swab and rinse limits - Microbial & endotoxin limits Sampling Methods - Swab sampling - Rinse sampling - Visual inspection Analytical Methods - Sensitivity and specificity of residue detection - LOD/LOQ validated methods Number of Runs Typically three consecutive successful cleaning runs to validate the process. Revalidation Requirements When to revalidate (e.g., changes in product, equipment, cleaning procedure). Roles and Responsibilities QA, Production, Validation, QC – defined via RACI or responsibility matrix. Documentation Required - Cleaning validation protocols and reports - SOPs - Equipment logs
Computer System Validation Ensures Software And Hardware Systems Perform Accurately And Reliably In Compliance With 21 CFR Part 11. Computer System Validation (CSV) is a mandatory part of the Validation Master Plan (VMP) for regulated pharmaceutical environments. It ensures that computerized systems used in GxP processes are reliable, accurate, secure, and compliant with regulatory requirements such as 21 CFR Part 11, EU Annex 11, and GAMP 5. Purpose of Including CSV in the VMP • Ensure data integrity, security, and traceability. • Confirm computerized systems function as intended and meet user requirements. • Establish a structured lifecycle validation approach. • Maintain compliance with regulatory expectations (FDA, EMA, MHRA, etc.).
Key Elements of CSV in a VMP Section Content Description Objective Define the aim of validating computerized systems used in GMP environments. Scope Systems covered: LIMS, ERP, SCADA, HPLC software, MES, document control, etc. Regulatory Framework FDA 21 CFR Part 11, EU Annex 11, GAMP 5, ICH Q9, ALCOA+ principles System Risk Classification Categorize systems based on GAMP 5 (e.g., Category 3–5) or impact on product quality. Validation Lifecycle Follows a lifecycle:
CSV Validation Plan Template (Summary Format) Section Description 1. Introduction Purpose, scope, and objectives of the validation plan 2. System Description Overview of the system (e.g., LIMS, MES, SCADA), including version and purpose 3. Scope of Validation Define modules/functions in scope (e.g., user management, reporting) 4. Risk Assessment GAMP 5-based risk assessment to determine validation depth 5. Validation Activities Lifecycle: URS → FS/DS → IQ → OQ → PQ → Release 6. Roles & Responsibilities QA, IT, Business Owner, Validation Lead – detailed RACI matrix 7. Deliverables Validation documents: protocol, scripts, traceability matrix, final report 8. Acceptance Criteria Clearly defined success criteria for each validation stage 9. Change Management Process for handling patches, updates, and system changes 10. Backup & Recovery Approach for ensuring data integrity and disaster recovery 11. Schedule Timeline of validation activities 12. Approval Signatures QA, System Owner, Validation Lead
Traceability Matrix Template (CSV) URS ID Functional Requirement Test Case ID Test Description Test Result Remarks URS-01 User login must be secure TC-01 Verify password complexity rules Pass/Fail URS-02 Audit trail functionality TC-02 Check system logs for changes Pass/Fail
GAMP 5 System Category Classification Chart GAMP Category System Type Example Validation Focus Category 1 Infrastructure Software Operating systems, database engines Qualified as part of IT infrastructure Category 3 Non-configurable Commercial Software Office tools (e.g., Excel), browsers Document intended use Category 4 Configured Software LIMS, ERP (configured via settings, not coded) Configuration management & testing Category 5 Custom/Bespoke Software In-house developed or heavily customized systems Full validation, SDLC documentation
Analytical Method Validation Confirms that analytical methods are suitable for their intended use in terms of accuracy, precision, specificity, and robustness. Analytical Method Validation (AMV) is a key component of the Validation Master Plan (VMP) in the pharmaceutical industry. It ensures that the analytical methods used for testing raw materials, intermediates, and finished products are scientifically sound, reproducible, and suitable for their intended purpose. Purpose of AMV in VMP •Confirm methods provide accurate, reliable, and consistent results. •Ensure compliance with regulatory expectations: • ICH Q2(R2) (newest) • USP <1225>, <1226> • EMA, FDA, WHO TRS
Key Elements of Analytical Method Validation in VMP Section Description Objective Define the scope and goals of method validation within the quality framework. Scope Covers methods for identity, assay, impurities, content uniformity, etc. Regulatory References ICH Q2(R2), USP, EP, JP, FDA Guidance Types of Methods Chromatographic (HPLC, GC), spectroscopic (UV, IR), titrimetric, etc. Validation Parameters Based on method type: accuracy, precision, specificity, linearity, range, LOD/LOQ, robustness, system suitability Validation Protocols Pre-approved documents outlining objectives, test plan, criteria, responsibilities Acceptance Criteria Defined per parameter and method per ICH and pharmacopeial guidelines Revalidation Criteria When method changes occur (equipment, reagents, procedure) Documentation Method SOP, protocol, raw data, validation report, summary tables Roles & Responsibilities QC Lab, QA, Method Developer, Regulatory Affairs
Typical Validation Parameters (ICH Q2) Parameter Applicable To Specificity All methods Linearity Quantitative methods Accuracy Quantitative methods Precision Repeatability and intermediate Detection Limit Impurities and limit tests Quantitation Limit Assay and impurity methods Robustness All methods System Suitability All methods with instrumentation
Revalidation Performed when changes occur or after a defined period to ensure continued compliance and performance. Revalidation ensures that validated systems, equipment, and processes remain in a state of control over time. It is a core element of the Validation Master Plan (VMP) to maintain compliance and product quality in pharmaceutical manufacturing. Purpose of Revalidation • To confirm that previously validated systems still meet predefined criteria. • Required when changes, deviations, or time-based intervals occur. • Ensures continued assurance of process performance and product quality.
Types of Revalidation Type Triggering Events Routine (Periodic) Time-based schedule (e.g., every 2–3 years), regardless of changes Change-Based After changes to equipment, process, utilities, software, or materials Deviation-Based Triggered by out-of-spec (OOS), out-of-trend (OOT), or critical deviations Product Discontinuation/Restart For systems not used over long periods and being reintroduced
Scope of Revalidation in VMP Area Revalidation Requirement Facilities & HVAC Structural modifications, new installations Equipment Relocation, major maintenance, software upgrades Utilities (Water, Air, Steam) Changes to generation/distribution systems Process Major changes to critical parameters, raw materials, batch size Cleaning Procedures Detergent change, new contact surface, failure in cleaning verification Computer Systems Software version updates, configuration changes Analytical Methods Modified procedures, new instruments
Key VMP Deliverables Related to Revalidation • Revalidation Schedule (calendar or tracker) • Change Control Records • Risk Assessment Reports • Revalidation Protocols & Reports • Deviation & Investigation Reports • Final Approval and QA Summary
Change Control Change Control is a formal system used to manage, document, and evaluate any changes that could impact the validated state of systems, processes, equipment, or facilities. It ensures product quality, safety, and regulatory compliance are maintained. Objective of Change Control in VMP To establish a structured process to: • Assess proposed changes. • Evaluate risks and impact. • Implement changes with necessary revalidation. • Maintain traceability and compliance.
Key Elements of Change Control in the VMP Component Description Scope Includes changes to equipment, processes, software, documents, and utilities Initiation Change is proposed and documented via a change control form (CCF) Impact Assessment Cross-functional risk evaluation (impact on quality, safety, validation status) Change Classification Minor, Major, or Critical (based on risk to validated state or compliance) Review & Approval QA, Validation, and Functional Owners must review and approve Implementati on Plan Includes actions, testing, training, and timelines Revalidation Decision Based on risk and impact; documented in the change control record Closure Verified post-implementation; QA confirms all actions completed
Change Control Workflow (Typical) 1. Initiate Change ↓ 2. Impact Assessment (QA/Validation/Engineering) ↓ 3. Determine Revalidation Requirement ↓ 4. Approval by Responsible Departments ↓ 5. Implementation ↓ 6. Verification & Documentation ↓ 7. QA Review & Closure Documentation & Tools •Change Control Form (CCF) •Risk Assessment Template •Change Log •Revalidation Justification Report •Deviation Linking (if applicable)
RiskAssessment in VMP Risk Assessment in the VMP provides a structured approach to identify, evaluate, and mitigate potential risks that may affect product quality, patient safety, and regulatory compliance during validation activities. Purpose of Risk Assessment in VMP •To apply science- and risk-based principles (aligned with ICH Q9). •To determine the scope and extent of validation activities. •To prioritize efforts based on risk level (High, Medium, Low). •To support change control, deviation, and revalidation decisions.
When Is Risk Assessment Used in VMP? Validation Activity Risk Assessment Application Facility and Equipment Assess potential for contamination, downtime, or failures Process Validation Identify critical process parameters (CPPs) and their variability Cleaning Validation Evaluate residue risk and cleaning effectiveness Computer System Validation Classify systems based on GAMP 5 and impact on product quality Analytical Method Validation Determine criticality of method accuracy and precision Change Control & Revalidation Evaluate impact of changes on validated state
Risk Assessment Tools Commonly Used in VMP Tool Purpose FMEA Failure Modes and Effects Analysis – for equipment/process analysis Risk Ranking Matrix Classify risk based on severity, probability, detectability Impact Assessment Qualitative or quantitative analysis for changes Hazard Analysis For utilities, facility design, or critical systems Typical Risk Ranking Criteria Risk Factor Low (1) Medium (2) High (3) Severity Minor impact Moderate impact Major risk to product/patient Probability Rarely occurs Occasionally occurs Frequently occurs Detectability Easily detected Detected with effort Difficult to detect
Validation Planning Validation Planning in a VMP outlines how validation activities will be structured, executed, and documented to ensure compliance with regulatory expectations (e.g., FDA, EMA, WHO). Key Components of Validation Planning in VMP Component Description Scope of Validation Defines systems, processes, and equipment included in the validation effort Validation Strategy Approach (e.g., prospective, concurrent, retrospective) based on risk Validation Schedule Timeline or Gantt chart outlining validation activities Resources Required Teams, departments, and third parties involved Documentation Plan Required protocols and reports (e.g., URS, DQ, IQ, OQ, PQ, summary reports) Roles & Responsibilities Assignment of responsibility for approvals, execution, review Acceptance Criteria Clear, measurable criteria to determine if validation is successful Deviation Management Procedures to handle unexpected results or deviations during validation
Example: Validation Timeline Month Activity Jan User Requirements Specification (URS) Feb–Mar Design Qualification (DQ), Installation Qualification (IQ) Apr–May Operational Qualification (OQ) Jun Performance Qualification (PQ) Jul Summary Report & Final Review
Document Control Document Control ensures that all validation-related documents are properly created, reviewed, approved, issued, distributed, revised, and archived in a controlled manner. Purpose in VMP To maintain the integrity, traceability, and regulatory compliance of all documents generated during validation activities. Key Elements of Document Control Aspect Description Document Numbering Unique ID assigned to each validation document for traceability Version Control Tracks changes and maintains current approved versions Approval Process Review and sign-off by QA, Validation, and other stakeholders Distribution Ensures only the current version is available for use Archiving & Retention Secure storage and retrieval for a defined retention period Access Control Limits editing/approval rights to authorized personnel Change History (Audit Trail) Records all document modifications with date and responsible person
Examples of Controlled Documents •Validation Master Plan (VMP) •Validation Protocols (IQ, OQ, PQ) •Risk Assessments •Traceability Matrix •Deviation Reports •Summary Reports •SOPs related to validation Best Practices •Use a Document Management System (DMS) or Electronic Document Management System (EDMS). •Implement periodic reviews and revisions based on product lifecycle or regulatory updates. •Include a Document Control SOP in the VMP.
Training Requirements in a Validation Master Plan Purpose of Training Requirements To ensure that all personnel involved in validation activities: •Understand their roles and responsibilities. •Possess adequate knowledge of GMP (Good Manufacturing Practice). •Are competent in using relevant equipment, procedures, and documentation practices. Who Needs to be Trained? • Validation team members • QA/QC personnel • Production and maintenance staff • Engineering teams • Data integrity and documentation personnel Types of Required Training • GMP & Regulatory Compliance Training • Validation Principles & Protocols (IQ, OQ, PQ) • Equipment Qualification Procedures • Cleaning Validation • Analytical Method Validation • Software/Computer System Validation • Deviation and Change Control Handling Training Methodologies • Classroom sessions • On-the-job training • SOP-based instructions • External workshops/seminars • E-learning modules (for periodic refreshers)
Training Documentation •Training records must be maintained as per GDP. •Each record should include: • Date of training • Trainer and trainee names • Content or SOPs covered • Evaluation results (if any) • Signatures for acknowledgment Evaluation of Training Effectiveness •Post-training assessments (quizzes or practical demos) •Supervisor observation and feedback •Periodic re-evaluation (e.g., annually) Retraining Triggers •SOP or regulatory changes •Equipment upgrades •After audits or non-compliance findings •Observed errors or incidents Responsibilities •QA Department: Ensures training needs are identified and met. •HR/Training Coordinator: Schedules and tracks training programs. •Supervisors: Ensure team participation and effectiveness. •Employees: Attend, understand, and implement training.
Training Requirements – Summary Table for VMP Element Details Objective Ensure personnel are qualified to perform validation activities. Personnel to be Trained Validation team, QA/QC, production, engineering, maintenance, IT staff. Training Topics GMP, IQ/OQ/PQ, equipment qualification, cleaning validation, data integrity. Training Methods Classroom, on-the-job, SOP-based, e-learning, external workshops. Training Frequency Initial (induction), periodic (e.g., annually), as needed (SOP changes). Evaluation Methods Written tests, practical demonstrations, supervisor evaluations. Training Records Maintained as per GDP; includes date, content, signatures, evaluations. Retraining Triggers SOP changes, audit findings, incidents, equipment changes. Responsible Departments QA, HR/Training Coordinator, Supervisors.
QualityAssurance Role – Summary Table QA Responsibility Details Review & Approve VMP, protocols (IQ/OQ/PQ), validation reports Compliance Oversight Ensures validation aligns with GMP and regulatory standards Documentation Control Manages SOPs, validation records, and training documents Deviation/CAPA Management Handles validation deviations and verifies effectiveness of CAPA Risk Assessment Participates in validation risk analysis and mitigation planning Training Verification Ensures all validation personnel are adequately trained Audit Participation Prepares for internal/external audits, addresses findings Continuous Improvement Suggests improvements in validation based on audit trends and feedback
Monitoring and Review Objective: To establish a structured approach for continuous oversight and periodic evaluation of validation activities to ensure sustained compliance and effectiveness. Key Components 1. Routine Monitoring •Regular tracking of validation progress against the VMP schedule. •Monitoring of validation metrics like completion rates, deviations, CAPA closure, etc. •Evaluation of system performance post-validation to detect drift or non- conformance. 2. Review Frequency •Typically conducted quarterly or annually depending on the scope and risk. •Triggered by events such as: • Change controls • Deviations • Audit observations • Product quality complaints 3. Review Activities •Review of: • Completed validation protocols and reports • Open and overdue validation items • Deviations and CAPAs • Training records •Comparison with regulatory expectations and industry best practices. 4. Outcomes of Review •Identification of areas needing revalidation. •Recommendations for changes in procedures, training, or documentation. •Update or revision of the VMP if necessary. •Enhanced planning for future validations. 5. Roles and Responsibilities •QA Department: Leads the review, records findings, initiates necessary actions. •Validation Team: Provides documentation and evidence. •Management: Approves any VMP updates or resource reallocations.
Monitoring and Review – Summary Table Aspect Details Purpose Ensure validation remains effective and compliant Frequency Quarterly, annually, or based on events (e.g., deviations, audits) What is Monitored? Validation timelines, deviations, CAPAs, performance, training, compliance Key Activities Document review, gap analysis, trend analysis, KPI tracking Responsible Parties QA (lead), validation team, management Outcomes Revalidation, updates to VMP, improved training or process controls
Example: Equipment Validation Element Details Equipment Name Tablet Compression Machine (e.g., Rimek Mini Press-II) Equipment ID EQP-TCM-001 Location Manufacturing Area – Solid Dosage Section Validation Type Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ) Purpose of Validation To ensure the machine is installed, operates, and performs as per specifications IQ Activities Verify installation against design specs, utility connections, part list OQ Activities Test operational functions: RPM, compression force, safety interlocks PQ Activities Trial batch compression, evaluate tablet weight, hardness, thickness uniformity Acceptance Criteria Must meet predefined specs and tolerances during all qualification phases Responsibility Engineering, Production, and Quality Assurance Validation Status Completed / Scheduled / In Progress Revalidation Frequency Every 2 years or upon major change Reference Documents Equipment Manual, Calibration SOP, Validation Protocol
Example: Process Validation – Summary Table Element Details Product Name Paracetamol 500 mg Tablets Batch No. for Validation PV001, PV002, PV003 (3 consecutive batches) Type of Validation Prospective Validation Purpose To establish documented evidence that the process is capable of producing acceptable product consistently Critical Process Steps Mixing, Granulation, Drying, Compression, Coating Critical Parameters Mixing time, granule moisture content, compression force, coating thickness Acceptance Criteria Must meet specifications for weight variation, hardness, friability, assay, dissolution Validation Activities Sampling at each stage, in-process testing, end-product testing Statistical Tools Standard deviation, RSD, process capability index (Cpk) Responsibilities Production (execution), QA (oversight & review), QC (testing) Documentation Process Validation Protocol, Batch Manufacturing Record (BMR), Validation Report Revalidation Criteria Process change, new equipment, failure investigation Status Completed / In Progress / Scheduled
Example: Cleaning Validation – Summary Table Element Details Equipment Name Fluid Bed Dryer (FBD) Product Cleaned From Metformin Hydrochloride Tablets Next Product Paracetamol Tablets Cleaning Method Manual cleaning using water and approved detergent, followed by drying Type of Validation Prospective / Concurrent / Periodic Sampling Methods Swab sampling & Rinse sampling Acceptance Criteria <10 ppm product residue, <100 CFU/ml microbial count, no visible residue Worst Case Determination Based on product solubility, potency, batch size, difficulty to clean Analytical Method Used HPLC for residue analysis, Bioburden for microbial limits No. of Validation Runs 3 consecutive successful cleanings Locations Sampled Hard-to-clean surfaces: corners, joints, outlet chute, filter housing Documentation Cleaning Validation Protocol, Sample Plan, Test Results, Final Report Revalidation Criteria Change in cleaning procedure, new product introduction, equipment modification Status Completed / Scheduled / In Progress
Deviation Management Objective of Deviation Management in VMP: • To establish a standardized and systematic approach for identifying, documenting, evaluating, and resolving deviations encountered during validation activities. • To ensure that all deviations are managed in compliance with regulatory requirements and do not compromise product quality, safety, or efficacy. • To ensure that appropriate corrective and preventive actions (CAPA) are implemented and monitored effectively. Purpose of Deviation Management in VMP: • To maintain control over validation processes by effectively addressing deviations from approved procedures or specifications. • To ensure transparency and traceability in handling non-conformities during validation. • To enable root cause analysis and continuous improvement through proper investigation and trending of deviations. • To minimize the risk of product defects, regulatory non-compliance, and process variability due to unaddressed deviations.
Deviation Management in Validation Master Plan (VMP) Aspect Description Definition A deviation is any departure from an approved process, instruction, or standard operating procedure (SOP) during validation. Purpose To ensure all deviations are properly identified, documented, investigated, and resolved to maintain product quality and compliance. Types of Deviations - Planned Deviation: Authorized change from a procedure with prior approval.- Unplanned Deviation: Unexpected departure during execution. Deviation Identification Any personnel involved in validation activities can report a deviation immediately upon noticing. Documentation All deviations must be recorded in a deviation report with detailed description, date/time, location, and responsible personnel. Investigation Process Root cause analysis (RCA) conducted to determine underlying cause(s). Tools: 5 Whys, Fishbone Diagram, etc. Impact Assessment Evaluate deviation impact on:- Product quality- Validation outcome- Regulatory compliance Corrective & Preventive Actions (CAPA) - Corrective Action: Fix the issue.- Preventive Action: Prevent recurrence. Approval & Closure QA/Validation Head reviews and approves closure of the deviation after CAPA implementation. Revalidation Trigger Significant deviations may trigger full or partial revalidation depending on the severity and impact. Trending & Monitoring Periodic review of deviation data to identify trends or repeated issues, improving future processes.
Validation Report Objective of Validation Report in VMP: •To formally document and summarize the outcome of a validation activity. •To verify that all validation steps were completed according to the protocol and met pre- defined acceptance criteria. •To ensure that the validated process, equipment, or system performs consistently and reproducibly within established specifications. Purpose of Validation Report in VMP: •To provide documented evidence that the system or process meets its intended use and regulatory requirements. •To serve as a comprehensive record for internal audits and external inspections. •To support decisions regarding the approval, continuation, or revalidation of equipment, processes, or systems. •To include deviations, investigations, CAPAs, and conclusions related to the validation exercise.
Validation Report in VMP – Summary Table Section Description Objective Summarizes the purpose and scope of the validation study System/Process Validated Name and description of the system, equipment, process, or method validated Validation Type Type of validation (e.g., Installation, Operational, Performance, Cleaning) Protocol Reference Identification number and title of the validation protocol used Execution Summary Summary of test execution, including dates and involved personnel Results Summary Overview of test results: passed/failed with justification Deviations Description of any deviations encountered and corrective actions taken Acceptance Criteria Whether acceptance criteria were met Conclusions Final conclusion about the state of validation (e.g., successful/failed) Recommendations Any recommendations for re-validation, preventive actions, or improvements Approval Signatures QA, validation, and relevant department heads approval with date
Auditing and Inspections In a Validation Master Plan (VMP), the "Auditing and Inspections" section outlines how validation processes are monitored and evaluated for compliance. Here's a structured summary table: Element Description Objective To verify that validation activities comply with internal procedures and regulations Types of Audits Internal audits, external audits, vendor audits, regulatory inspections Audit Frequency Defined periodicity (e.g., annual, biannual) depending on system/process criticality Responsible Department Quality Assurance (QA) or Compliance department Audit Scope Includes validation protocols, reports, data integrity, equipment logs, etc. Inspection Readiness Ensures all documentation is complete, traceable, and readily available Follow-Up and CAPA Corrective and Preventive Actions to address audit findings Documentation Audit reports, checklists, compliance certificates Regulatory Bodies Involved Examples: FDA, EMA, WHO, local health authorities Review and Approval Validation and QA management must review and approve audit findings Auditing and Inspections in VMP – Summary Table
Common VMPMistakes Mistake Description Impact 1. Vague Objectives Lack of clear scope or purpose of the validation activities Leads to confusion and inconsistent implementation 2. Incomplete System Inventory Missing list of all systems/equipment/processes to be validated Critical systems may be excluded from validation 3. Poor Risk Assessment No or inadequate risk-based approach to validation priorities Resources are misallocated; non- critical systems overemphasized 4. Lack of Traceability Missing links between user requirements, test cases, and results Compromises compliance and audit readiness 5. Undefined Roles & Responsibilities No clarity on who does what in validation Causes delays, accountability issues, and poor execution 6. Outdated References Use of obsolete standards (e.g., old GAMP or ICH guidelines) Regulatory non-compliance 7. Weak Change Control Integration Change control not tied into the validation lifecycle Unauthorized changes can go unvalidated 8. Inconsistent Documentation Practices Inadequate version control, unsigned documents, or missing approvals Leads to audit findings and poor data integrity 9. Missing Revalidation Criteria No guidance on when to revalidate after changes or time periods May result in operating non- compliant systems 10. Poor Review & Approval Process VMP not formally reviewed or approved by QA and management Lack of ownership and oversight
Best Practices in a Master Validation Plan (VMP) Category Best Practice Why It Matters 1. Clear Scope & Objectives Clearly define what systems, equipment, and processes are covered. Helps align stakeholders and avoid scope creep. 2. Risk-Based Approach Prioritize validation activities based on risk to product quality and patient safety (aligned with ICH Q9 or GAMP 5). Focuses resources where they matter most. 3. Comprehensive System Inventory Include a validated system inventory with classification (e.g., GAMP categories). Ensures no critical system is overlooked. 4. Defined Roles & Responsibilities Assign QA, validation, engineering, and IT responsibilities in the MVP. Enables accountability and smooth execution. 5. Document Traceability Link user requirements → protocols → test results → final reports. Provides audit-ready traceability. 6. Integrated Change Control Tie validation requirements into the Change Control process. Ensures validated state is maintained post-change. 7. Lifecycle-Based Planning Cover Installation, Operational, and Performance Qualification (IQ/OQ/PQ). Ensures complete validation lifecycle. 8. Qualification Strategy Define qualification strategies for equipment, utilities, software, etc. Promotes consistent and efficient execution. 9. Revalidation Strategy Include periodic review, triggers, and criteria for revalidation. Keeps systems compliant over time. 10. Audit Preparedness Ensure the MVP is regularly reviewed, up- to-date, and aligned with current regulatory expectations. Minimizes audit risks.
CommonAnnexures in a VMP Annexure No. Title Description Annexure I Validation Inventory List Complete list of systems, equipment, utilities, and processes requiring validation. Often categorized by type (e.g., GMP-critical vs. non-critical). Annexure II Validation Schedule Timeline or Gantt chart showing planned validation activities and milestones. Annexure III System Classification (e.g., GAMP Category) Classification of computerized systems according to GAMP 5 categories (e.g., Category 3, 4, 5). Annexure IV Risk Assessment Summary Output of risk assessments used to prioritize validation efforts. May include tools like FMEA or Risk Ranking. Annexure V Validation Document Matrix A traceability matrix linking URS, DQ, IQ, OQ, PQ, test cases, and reports. Annexure VI Change Control Log Historical record of changes affecting validated systems or processes. Annexure VII Training Records Evidence that validation team members are trained and qualified. Annexure VIII Vendor Qualification Records Includes audit reports or questionnaires for critical suppliers or service providers. Annexure IX Revalidation Criteria Lists conditions that trigger revalidation, including periodic review intervals. Annexure X Glossary of Terms & Abbreviations Ensures clarity of technical and regulatory language. Annexure XI List of Referenced SOPs/Documents Includes SOPs, guidelines, or external standards referenced in the VMP. Annexure XII Audit and Inspection Findings Summary Documents past audit observations and related CAPA linked to validation.
Regulatory Updates The Regulatory Updates section of a VMP ensures that the validation strategy remains aligned with current regulatory expectations, guidance, and industry best practices. This is critical for maintaining compliance during inspections and audits. Purpose of Including Regulatory Updates in VMP •Demonstrate awareness and integration of current regulations and guidance. •Ensure that validation activities reflect up-to-date regulatory requirements. •Support risk-based approaches by linking them to the latest industry standards. Best Practices •Review and update this section annually or upon major regulatory changes. •Link updates directly to validation SOPs or change controls. •Maintain a Regulatory Change Log as an annexure.
Component Details Title Regulatory Landscape and Updates Objective Outline the framework of applicable regulatory guidelines and any recent updates impacting validation. Sources List of reference documents from:– FDA (e.g., 21 CFR Part 11, Part 210/211)– EU Annex 15– ICH Guidelines (e.g., Q8, Q9, Q10)– WHO, PIC/S, ISPE, GAMP 5– Local health authorities Recent Changes Summary of recent or significant regulatory changes (e.g., new FDA guidance on Computer Software Assurance, updated EU GMP Annexes) Impact on Validation Describe how updates affect:– Validation lifecycle– Documentation– Risk assessment– Frequency of revalidation– Data integrity requirements Action Plan List of changes made or planned in the VMP or validation strategy to address these updates. What to Include in the Regulatory Updates Section
Case Study: FDA 483 Due to Poor Validation Company Profile: •Type: Pharmaceutical Manufacturer (Sterile injectables) •Location: U.S.-based facility •Inspection Year: 2022 •Regulatory Body: U.S. FDA Observation from FDA 483: "Your firm failed to adequately validate the sterilization process used for drug product manufacturing. Specifically, your media fill simulations lacked proper documentation, acceptance criteria, and requalification strategy." Key Validation Failures Identified: Area Issue Process Validation Media fill protocols did not match commercial manufacturing conditions. No documented rationale for frequency or sampling plan. Revalidation No periodic revalidation schedule for critical aseptic processes. Data Integrity Media fill results were missing batch records and lacked real-time entry controls. Change Control Changes in sterilization cycle parameters were implemented without impact assessment or revalidation. Training Operators conducting validation were not documented as trained on revised SOPs.
Consequences: •FDA issued Form 483 with multiple observations. •Follow-up Warning Letter within 3 months due to repeat observations. •Firm had to initiate a product recall and suspend production. •Costly remediation: external consultants, revalidation of all aseptic processes, retraining of staff. Lessons Learned & Preventive Actions: Lesson Corrective Action (CAPA) Incomplete validation protocols Implement a protocol template checklist; QA to review all validation protocols pre-approval. Lack of periodic revalidation Add automated revalidation triggers to the change control system and annual validation calendar. Poor documentation Adopt an electronic document management system (EDMS) for version control and audit trails. Unqualified personnel Require documented training before involvement in validation activities. Non-compliant change control Integrate QA review of all changes impacting validated systems.
How to Apply This in VMP: •Include a section: "Case Studies and Industry Learnings" •Add a risk mitigation strategy aligned with these learnings •Tie in CAPAs with your validation SOPs, training programs, and change control procedures
Key Benefits of a Robust VMP Benefit Why It Matters 1. Regulatory Compliance Ensures all validation activities comply with FDA, EMA, WHO, MHRA, and other regulatory bodies. Prevents 483s, warning letters, and product recalls. 2. Risk Management Supports a systematic, risk-based approach (e.g., ICH Q9, GAMP 5) that focuses resources on critical systems and processes. 3. Consistency & Standardization Establishes uniform procedures and documentation practices across all departments and facilities. 4. Improved Audit Readiness Demonstrates control and traceability of validation lifecycle, making inspections more manageable and less stressful. 5. Enhanced Quality Assurance Provides evidence that equipment, systems, and processes consistently perform as intended, protecting product quality and patient safety. 6. Efficient Change Control Integrates validation into the change management process, ensuring revalidation when needed and preventing unintended compliance gaps. 7. Better Resource Planning Allows scheduling of validation activities, avoiding overlaps, downtime, and resource conflicts. 8. Clear Roles & Responsibilities Clearly defines team responsibilities, improving accountability and communication. 9. Continuous Improvement Promotes regular review and updating of validation activities based on trends, CAPAs, and regulatory changes. 10. Cost Reduction Over Time Prevents expensive remediation, product failures, and rework by getting validation right the first time.
Conclusion The Validation Master Plan (VMP) is a critical, high-level document that outlines a company's overall strategy and approach to validation across systems, equipment, facilities, utilities, processes, and computer systems. A well-structured VMP ensures that all validation activities are planned, executed, and documented in a consistent, risk-based, and compliant manner. Key Takeaways: • The VMP serves as a roadmap for ensuring that systems and processes meet regulatory requirements (e.g., FDA, EMA, WHO). • It defines validation objectives, scope, responsibilities, documentation requirements, revalidation triggers, and risk management strategies. • Proper implementation of the VMP ensures data integrity, product quality, and patient safety. • Integration of GAMP 5, ICH guidelines, and change control mechanisms enhances the robustness of the validation framework. • Regular review and updates of the VMP keep the organization aligned with current regulatory expectations and industry best practices. “A robust VMP is not just a regulatory requirement — it is a cornerstone of a company’s quality and compliance strategy.”
Thank You! Thank you for your attention and commitment to quality and compliance. A well-executed VMP not only fulfills regulatory requirements but lays the foundation for operational excellence and patient safety. "Validation is not a one-time task — it’s a culture of accountability. A strong VMP transforms compliance from a checkbox into a commitment." — Quality Assurance Principle

More Related Content

PPT
Validation regulatory review
byPRANJAY PATIL
 
PPTX
ICH Q8 Guidelines
byMANIKANDAN V
 
PPTX
Scale up post approval changes
byROHIT
 
PPTX
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
bySchool of Pharmacy, SRTM University Nanded-431606 Maharashtra, India
 
PPTX
Protein and peptides drug delivery systems
byVINOTH R
 
PPTX
Rest of world(row) Naveen Balaji
byNaveen Balaji
 
PPTX
Drug Master File submissions
byArshad Khan
 
PPTX
Product Stability Studies & Stability Testing
byAmit Attri
 
Validation regulatory review
byPRANJAY PATIL
 
ICH Q8 Guidelines
byMANIKANDAN V
 
Scale up post approval changes
byROHIT
 
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
bySchool of Pharmacy, SRTM University Nanded-431606 Maharashtra, India
 
Protein and peptides drug delivery systems
byVINOTH R
 
Rest of world(row) Naveen Balaji
byNaveen Balaji
 
Drug Master File submissions
byArshad Khan
 
Product Stability Studies & Stability Testing
byAmit Attri
 

What's hot

PPTX
Pharmaceutical validation
byMineeta Mahra
 
PPTX
Urs,dq, iq,oq,pq
byMāľāý Păųļ
 
PPTX
Validation regulatory review
byArpitSuralkar
 
PPTX
ICH Guideline Q8 Pharmaceutical Development
byBINDIYA PATEL
 
PPTX
Ich Q8 Pharmaceutical Development( comparison with Q9 and Q10 )
byDhrutiPatel61
 
PPTX
USFDA guidelines of glp for non clinical testing laboratories
byswrk
 
PPTX
rules, regulation and guideline for medical devices
byCharmi13
 
PDF
Computer system validation review article by-mahesh b wazade
byMahesh B. Wazade
 
PPTX
CASE STUDY ON CHANGE CONTROL
byJAYA PRAKASH VELUCHURI
 
PPTX
REGULATORY AFFAIRS & MASTER FORMULA RECORD
bysachin suryawanshi
 
PPTX
Regulation of biosimilar in India
byPalesh Rajkondawar
 
PPTX
Dossier Preparation/ CTD (Common Technical Document)
byPrakash Ghimire
 
PPTX
REGULATORY REQUIREMENTS FOR APPROVAL OF API
bynivedithag131
 
PPT
Copp- Certificate of Pharmaceutical Products
byDr. Jigar Vyas
 
PPTX
Drug master file
byVrushaliSonar
 
PPTX
BIOEQUIVALENCE STUDIES.pptx
byShiva Kant Thakur
 
PPTX
Design & development of implantable products: By Bhupendra Yadav
byRavishankar University, Raipur
 
PPTX
Cosmetics regulations
bySUJITHA MARY
 
PPTX
hatch-waxman act@amendments
byBharati vidyapeeth college of pharmacy, kolhapur
 
PPTX
Bio Adhesive Drug Delivery System
byoptimpharma
 
Pharmaceutical validation
byMineeta Mahra
 
Urs,dq, iq,oq,pq
byMāľāý Păųļ
 
Validation regulatory review
byArpitSuralkar
 
ICH Guideline Q8 Pharmaceutical Development
byBINDIYA PATEL
 
Ich Q8 Pharmaceutical Development( comparison with Q9 and Q10 )
byDhrutiPatel61
 
USFDA guidelines of glp for non clinical testing laboratories
byswrk
 
rules, regulation and guideline for medical devices
byCharmi13
 
Computer system validation review article by-mahesh b wazade
byMahesh B. Wazade
 
CASE STUDY ON CHANGE CONTROL
byJAYA PRAKASH VELUCHURI
 
REGULATORY AFFAIRS & MASTER FORMULA RECORD
bysachin suryawanshi
 
Regulation of biosimilar in India
byPalesh Rajkondawar
 
Dossier Preparation/ CTD (Common Technical Document)
byPrakash Ghimire
 
REGULATORY REQUIREMENTS FOR APPROVAL OF API
bynivedithag131
 
Copp- Certificate of Pharmaceutical Products
byDr. Jigar Vyas
 
Drug master file
byVrushaliSonar
 
BIOEQUIVALENCE STUDIES.pptx
byShiva Kant Thakur
 
Design & development of implantable products: By Bhupendra Yadav
byRavishankar University, Raipur
 
Cosmetics regulations
bySUJITHA MARY
 
hatch-waxman act@amendments
byBharati vidyapeeth college of pharmacy, kolhapur
 
Bio Adhesive Drug Delivery System
byoptimpharma
 

Similar to Validation Master Plan (VMP) in Pharmaceutical.pptx

PPTX
Validation and calibration master plan
byBharatlal Sain
 
PPTX
Pharmaceutical Qualification & Validation
byPharmaceutical
 
PPTX
Validation and calibration of master plan
byPrinka Choudhary
 
PPTX
Validation master plan
byPriyanka Kandhare
 
PPTX
VALIDATION AND CALIBRATION OF PHARMACEUTICAL EQUIPMENTS.pptx
byLaniyaNasrink
 
PPTX
Pharmaceutical process validation.pptx
byPharmacy
 
PPTX
ValidationMasterPlan
byPinalPatel248485
 
DOCX
Pharmaceutical validation
byMuthu Maharaja Mla
 
PPTX
Qualification and validation
byArchana Mandava
 
PPTX
Validation Master Plan Modern Pharmaceutics
byMittalGandhi
 
PPTX
validationandcalibrationmasterplan-190223191733.pptx
byTanmayPanigrahy
 
PPTX
VMP.pptx
byMahesh Dhedhi
 
PPTX
Vish- Validation Master Plan
byVishal Parikh
 
PPTX
Validation
byABIYA SARA CHERIAN
 
PPTX
Validation
byTarif Hussian
 
PPTX
Pharmaceutical process validation.pptx
byPharmacy
 
PDF
Pharmaceutical Validation.pdf
byGireesh Kumar Eri
 
PPTX
Validation Principles in Pharmaceutical Industry
bycoheco4013
 
PPTX
Pharmaceutical validation
byMadhavMady3
 
PPTX
Presentation1.pptx
byabdo badr
 
Validation and calibration master plan
byBharatlal Sain
 
Pharmaceutical Qualification & Validation
byPharmaceutical
 
Validation and calibration of master plan
byPrinka Choudhary
 
Validation master plan
byPriyanka Kandhare
 
VALIDATION AND CALIBRATION OF PHARMACEUTICAL EQUIPMENTS.pptx
byLaniyaNasrink
 
Pharmaceutical process validation.pptx
byPharmacy
 
ValidationMasterPlan
byPinalPatel248485
 
Pharmaceutical validation
byMuthu Maharaja Mla
 
Qualification and validation
byArchana Mandava
 
Validation Master Plan Modern Pharmaceutics
byMittalGandhi
 
validationandcalibrationmasterplan-190223191733.pptx
byTanmayPanigrahy
 
VMP.pptx
byMahesh Dhedhi
 
Vish- Validation Master Plan
byVishal Parikh
 
Validation
byABIYA SARA CHERIAN
 
Validation
byTarif Hussian
 
Pharmaceutical process validation.pptx
byPharmacy
 
Pharmaceutical Validation.pdf
byGireesh Kumar Eri
 
Validation Principles in Pharmaceutical Industry
bycoheco4013
 
Pharmaceutical validation
byMadhavMady3
 
Presentation1.pptx
byabdo badr
 

Recently uploaded

PPTX
Віртуальна виставка «Гра в життя» – «The Game of Life»
byVinnytsia Regional Universal Scientific Library named after Valentin Otamanovsky
 
PPTX
Palta Utsav Open to All Quiz Final Set.pptx
bySourav Kr Podder
 
PDF
eSAT-for-Teachers-2025-2028-ver.2-Nov2025 idp.pdf
byJunmelValientes
 
PDF
19 January 2026 Andreas Schleicher Digital Education Outlook 2026.pdf
byEduSkills OECD
 
PPTX
PLATELET RICH PLASMA in regenerative med
byDr SMRUTI REKHA HOTA
 
PDF
Caribbean Examinations Council Literacy and Numeracy Standards
byCaribbean Examinations Council
 
PDF
3.Empires-and-Kingdoms-6th-to-10th-Centuries ppt.pdf/Social science Grade 7 p...
bySandeep Swamy
 
PDF
Fidelity to Energy: A Critical Analysis of Baz Luhrmann’s Intersemiotic Trans...
byKruti Vyas
 
PDF
Myth_History_Climate__Reading_Gun_Island.pdf
byBhargav Makwana
 
PDF
PULSE according to Physiology special pdf for all medical sectors students & ...
byhttps://www.facebook.com/profile.php?id=61578457231735
 
PDF
2.India-and-Her-Neighbours ppt.pdf/Social science Grade 7 part -2 By:K SANDE...
bySandeep Swamy
 
PPTX
Regenerate invoice in odoo 19 Accounting
byCeline George
 
PPTX
Capacity Building Programme for Teachers on Equitable and Inclusive Education
byMUKHTAR133762
 
PPTX
History in your Hands Class 5 January 2026 online slides.pptx
byEilsONeill
 
PPTX
When UDL is no longer enough: Examining post-UDL reflections on inclusive des...
byFrederic Fovet
 
PPTX
Birthday Field in Employee Records Odoo 19
byCeline George
 
PPTX
special senses-eye, ear, nose, tongue.pptx
byAshish Umale
 
PPTX
Throat painting and throat swab.....pptx
byAneetaSharma15
 
PPTX
How to add bank Account in Odoo 19
byCeline George
 
PPTX
Overview of SEO optimiser in Odoo 19 Website
byCeline George
 
Віртуальна виставка «Гра в життя» – «The Game of Life»
byVinnytsia Regional Universal Scientific Library named after Valentin Otamanovsky
 
Palta Utsav Open to All Quiz Final Set.pptx
bySourav Kr Podder
 
eSAT-for-Teachers-2025-2028-ver.2-Nov2025 idp.pdf
byJunmelValientes
 
19 January 2026 Andreas Schleicher Digital Education Outlook 2026.pdf
byEduSkills OECD
 
PLATELET RICH PLASMA in regenerative med
byDr SMRUTI REKHA HOTA
 
Caribbean Examinations Council Literacy and Numeracy Standards
byCaribbean Examinations Council
 
3.Empires-and-Kingdoms-6th-to-10th-Centuries ppt.pdf/Social science Grade 7 p...
bySandeep Swamy
 
Fidelity to Energy: A Critical Analysis of Baz Luhrmann’s Intersemiotic Trans...
byKruti Vyas
 
Myth_History_Climate__Reading_Gun_Island.pdf
byBhargav Makwana
 
PULSE according to Physiology special pdf for all medical sectors students & ...
byhttps://www.facebook.com/profile.php?id=61578457231735
 
2.India-and-Her-Neighbours ppt.pdf/Social science Grade 7 part -2 By:K SANDE...
bySandeep Swamy
 
Regenerate invoice in odoo 19 Accounting
byCeline George
 
Capacity Building Programme for Teachers on Equitable and Inclusive Education
byMUKHTAR133762
 
History in your Hands Class 5 January 2026 online slides.pptx
byEilsONeill
 
When UDL is no longer enough: Examining post-UDL reflections on inclusive des...
byFrederic Fovet
 
Birthday Field in Employee Records Odoo 19
byCeline George
 
special senses-eye, ear, nose, tongue.pptx
byAshish Umale
 
Throat painting and throat swab.....pptx
byAneetaSharma15
 
How to add bank Account in Odoo 19
byCeline George
 
Overview of SEO optimiser in Odoo 19 Website
byCeline George
 

Validation Master Plan (VMP) in Pharmaceutical.pptx

  • 1.
    Validation Master Plan(VMP) in Pharmaceutical Industry AN OVERVIEW OF THE VALIDATION MASTER PLAN – A KEY DOCUMENT IN ENSURING GMP COMPLIANCE. Dr Seema A Gosavi Associate Professor Department of Pharmaceutical Chemistry Sanjivani College of Pharmaceutical Education and Research, Kopargaon E-mail: seemagosavibpharm@sanjivani.org.in Mobile: 9860077084
  • 2.
    Learning Objectives: • Understandthe concept and importance of the Validation Master Plan (VMP). • Identify the key components, roles, and responsibilities associated with a VMP. • Explain the validation lifecycle and associated documentation. • Recognize the regulatory requirements and compliance aspects.
  • 3.
    Learning Outcomes:  Studentswill be able to define and describe the purpose of a VMP.  Students will identify and explain various types of validation (equipment, process, cleaning, etc.).  Students will interpret the structure of a VMP and list key regulatory references.  Students will evaluate the impact of validation failures and propose mitigation strategies.
  • 4.
    Introduction  Validation isa fundamental requirement in pharmaceutical manufacturing.  Ensures consistent quality, safety, and efficacy of products.  VMP is the backbone of validation activities. Definition: A Validation Master Plan (VMP) is a comprehensive document that outlines the overall strategy and approach for validation activities within a pharmaceutical manufacturing facility. It serves as a roadmap for ensuring that all processes, equipment, and systems meet predetermined quality standards and regulatory requirements.
  • 5.
    What is aValidation Master Plan? • A high-level document describing the company’s approach to validation. • Defines the scope, strategy, and responsibilities. • Covers facilities, systems, equipment, and processes.
  • 6.
    Purpose of VMP •Ensure product quality and regulatory compliance • Provide structured validation activities • Demonstrate GMP adherence • To provide a framework for all validation activities. • To define responsibilities, timelines, and scope of validation. • To ensure compliance with regulatory guidelines (e.g., FDA, EMA, WHO, PIC/S). • To ensure product quality, safety, and efficacy through validated processes. • To coordinate validation efforts and avoid duplication.
  • 7.
    Scope of theVMP Includes Facilities, Utilities, Equipment, Cleaning, Computer Systems, And Analytical Methods That Affect Product Quality. • Defines which systems, equipment, processes, and utilities are covered. • May include production, packaging, cleaning, utilities, computerized systems, etc. • Manufacturing processes • Facilities and utilities • Equipment and software systems • Cleaning and analytical methods
  • 8.
    Regulatory Expectations • WHOTRS 937 • EU GMP Annex 15 • US FDA guidelines • ICH Q8, Q9, Q10 Regulatory Body Key Document / Regulation VMP Requirement Highlight FDA 21 CFR Parts 210 & 211 Written validation procedures; validation plan FDA Process Validation Guidance (2011) Risk-based validation strategy & documentation EMA EU GMP Annex 15 Validation Master Plan mandatory; detailed scope and strategy PIC/S PIC/S Guide Annex 15 VMP content, roles, responsibilities, change control WHO WHO GMP Guidelines Validation plan for critical processes/systems
  • 9.
    Key Components ofVMP Component Description 1. Introduction Overview of the facility, manufacturing processes, and purpose of the VMP. 2. Scope Defines which systems, processes, equipment, and utilities are covered under the VMP. 3. Validation Policy Company’s overall approach and commitment to validation, aligned with regulatory requirements. 4. Organizational Structure and Responsibilities Roles and responsibilities of the validation team and involved departments (QA, Production, etc.). 5. Validation Strategy Description of validation types (process, equipment, cleaning, computerized systems) and risk-based approach. 6. Validation Lifecycle and Documentation Stages of validation (DQ, IQ, OQ, PQ), protocol and report requirements, documentation control. 7. Schedule and Timeline Timeline and prioritization for validation activities, including project milestones. 8. Change Control Procedures for managing changes impacting validated systems and when revalidation is necessary. 9. Training Training requirements and plans for personnel involved in validation activities. 10. Deviation and CAPA Management Handling deviations during validation and implementing corrective/preventive actions. 11. References List of regulatory guidelines, SOPs, and standards referenced in the VMP.
  • 10.
    Structure of aVMP Document  Introduction and validation policy  Organizational responsibilities  Validation strategy and schedule  Documentation and reporting
  • 11.
    Validation Policy Definition: The ValidationPolicy is a formal statement that outlines the company’s commitment and approach to validation. It sets the foundation for all validation activities and ensures alignment with regulatory requirements and industry best practices. Purpose of the Validation Policy: • To establish a clear and consistent approach to validation across the organization. • To ensure that all processes, equipment, systems, and methods affecting product quality are validated. • To comply with regulatory expectations and good manufacturing practices (GMP). • To support product quality, safety, and efficacy through effective validation.
  • 12.
    Roles and Responsibilities •QualityAssurance: Oversight and approvals •Engineering: Equipment validation •Manufacturing: Process knowledge and SOP adherence Role Responsibilities Validation Manager - Develops and maintains the VMP - Oversees all validation activities - Approves protocols/reports Quality Assurance (QA) - Reviews/approves VMP, protocols, and reports - Ensures compliance with GxP and regulatory guidelines - Manages deviations and CAPAs Validation Engineer - Drafts and executes validation protocols (IQ, OQ, PQ) - Records results - Investigates deviations Process Owner / Dept. Head - Provides technical input for validation - Ensures validated systems are used properly - Supports re-validation efforts Engineering / Maintenance - Installs/calibrates equipment - Provides technical documentation - Supports validation and change control Regulatory Affairs - Ensures validation aligns with regulations - Supports inspections and submissions with validation data IT / CSV Team - Validates computerized systems - Ensures 21 CFR Part 11 and data integrity compliance - Maintains system validation
  • 13.
    Validation Lifecycle Design Qualification(DQ), Installation Qualification (IQ) , Operational Qualification (OQ), Performance Qualification (PQ) Phase Objective Key Deliverables / Activities 1. Planning Define scope, responsibilities, and strategy for validation - Validation Master Plan (VMP) - Risk Assessment - Project Plan 2. Design Qualification (DQ) Verify design meets intended purpose and regulatory requirements - User Requirements Specification (URS) - Functional/Design Specs - DQ Report 3. Installation Qualification (IQ) Verify equipment/system is installed correctly and per specifications - IQ Protocol - Calibration & Utility Verification - IQ Report 4. Operational Qualification (OQ) Verify the system operates as intended under all conditions - OQ Protocol - Test Scripts - Alarm/Function Testing - OQ Report 5. Performance Qualification (PQ) Verify the system performs consistently in real-world scenarios - PQ Protocol - Batch/Process Testing - PQ Report 6. Validation Report / Summary Summarize results and determine validation acceptance - Validation Summary Report - Deviations & CAPAs addressed 7. Maintenance / Revalidation Maintain validated state and manage changes over time - Change Control - Periodic Review - Revalidation Plan 8. Decommissioning (if applicable) Ensure proper retirement of systems while maintaining data integrity - Decommissioning Plan - Data Archival - Final Validation Status
  • 14.
    Facility and EquipmentValidation Ensures that the facility and equipment operate as intended and meet GMP standards. Section Details Equipment/Facility Name (Enter the specific equipment or area being validated) Equipment/Facility ID (Asset tag, serial number, or internal ID) Location (Room number, department, site) Manufacturer / Model (Equipment manufacturer and model) Validation Type ☐ New Installation Re-Validation Periodic Review ☐ ☐ Validation Dates Start: __________ End: __________ Validation Protocols Executed ☐ DQ IQ OQ PQ ☐ ☐ ☐ Key Test Parameters (List critical parameters such as temperature, pressure, airflow, etc.) Acceptance Criteria (Specify the acceptance criteria for each test stage) Deviations Noted (Summarize any deviations and their resolution) Validation Status ☐ Passed Failed Pending Review ☐ ☐ Responsible Person (Name and designation of the person responsible for validation) Reviewed By (QA) (Name, signature, and date) Approval Validation Manager Signature: ____________ Date: ____________
  • 15.
    Process Validation Definition ofProcess Validation “Process Validation is the collection and evaluation of data, from the process design stage through commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality product.” — FDA Guidance for Industry Type Description 1. Prospective Validation Conducted before the product is released; most common for new processes. 2. Concurrent Validation Conducted during actual production of commercial batches (e.g., urgent cases). 3. Retrospective Validation Based on historical data of already marketed products (rarely used now). 4. Revalidation Repeated validation due to changes in process, equipment, facility, etc.
  • 16.
    In a ValidationMaster Plan (VMP), process validation is a core section that outlines the strategy, scope, and responsibilities for validating pharmaceutical manufacturing processes. It provides a high- level roadmap to ensure consistent product quality and compliance with regulatory requirements (e.g., FDA, EMA, WHO, ICH Q8-Q10). Purpose of Including Process Validation in VMP  Ensure all critical processes are validated before commercial production.  Establish a standardized approach for process qualification.  Meet regulatory expectations for lifecycle validation.  Provide traceability and control across all stages of validation. Process Validation
  • 17.
    Key Elements ofProcess Validation in a VMP Section Content Description Objective Define the purpose of process validation and its role in assuring product quality. Scope Covers all manufacturing processes, including critical steps and control strategies. Regulatory References ICH Q8-Q10, FDA Guidance (2011), EU Annex 15, WHO TRS, etc. Validation Approach Lifecycle-based approach (Process Design, Qualification, Continued Verification). Types of Validation Prospective, Concurrent, Retrospective (if justified), and Revalidation. Process Qualification Strategy Outline how many batches will be validated, sampling plan, and statistical justification. Roles and Responsibilities QA, Production, Validation team, Engineering—clearly defined in a RACI matrix. Documentation Process validation protocols, reports, batch records, deviations, CAPAs. Change Control Criteria for revalidation in case of process changes. Risk Assessment Application of Quality Risk Management (QRM) to determine validation scope and depth. Continued Process Verification Plan for ongoing monitoring (e.g., trending, statistical process control).
  • 18.
    Establishes documented evidencethat cleaning procedures remove residues to an acceptable level. Cleaning Validation in the Validation Master Plan (VMP) Cleaning Validation is a crucial section of the Validation Master Plan (VMP) in pharmaceutical manufacturing. It ensures that cleaning procedures effectively remove product residues, cleaning agents, and contaminants from equipment to prevent cross- contamination and ensure product quality. Purpose of Cleaning Validation in the VMP •Demonstrate that cleaning processes consistently meet predefined acceptance criteria. •Ensure compliance with regulatory requirements (FDA, EU GMP, WHO, PIC/S). •Prevent cross-contamination and ensure patient safety.
  • 19.
    Key Elements ofCleaning Validation in the VMP Section Content Objective Define the purpose of cleaning validation within the overall validation strategy. Scope Identify which equipment, products, and cleaning procedures are covered. Regulatory References FDA 21 CFR Part 211, EU Annex 15, WHO TRS 937, PIC/S PI 006, ICH Q9. Cleaning Strategies - Product-specific vs. campaign-based cleaning - Manual vs. automated (CIP/SIP) methods Worst-Case Selection Justification of worst-case product/equipment for validation studies. Acceptance Criteria - Residue limits (MACO – Maximum Allowable Carry Over) - Swab and rinse limits - Microbial & endotoxin limits Sampling Methods - Swab sampling - Rinse sampling - Visual inspection Analytical Methods - Sensitivity and specificity of residue detection - LOD/LOQ validated methods Number of Runs Typically three consecutive successful cleaning runs to validate the process. Revalidation Requirements When to revalidate (e.g., changes in product, equipment, cleaning procedure). Roles and Responsibilities QA, Production, Validation, QC – defined via RACI or responsibility matrix. Documentation Required - Cleaning validation protocols and reports - SOPs - Equipment logs
  • 20.
    Computer System Validation EnsuresSoftware And Hardware Systems Perform Accurately And Reliably In Compliance With 21 CFR Part 11. Computer System Validation (CSV) is a mandatory part of the Validation Master Plan (VMP) for regulated pharmaceutical environments. It ensures that computerized systems used in GxP processes are reliable, accurate, secure, and compliant with regulatory requirements such as 21 CFR Part 11, EU Annex 11, and GAMP 5. Purpose of Including CSV in the VMP • Ensure data integrity, security, and traceability. • Confirm computerized systems function as intended and meet user requirements. • Establish a structured lifecycle validation approach. • Maintain compliance with regulatory expectations (FDA, EMA, MHRA, etc.).
  • 21.
    Key Elements ofCSV in a VMP Section Content Description Objective Define the aim of validating computerized systems used in GMP environments. Scope Systems covered: LIMS, ERP, SCADA, HPLC software, MES, document control, etc. Regulatory Framework FDA 21 CFR Part 11, EU Annex 11, GAMP 5, ICH Q9, ALCOA+ principles System Risk Classification Categorize systems based on GAMP 5 (e.g., Category 3–5) or impact on product quality. Validation Lifecycle Follows a lifecycle:
  • 22.
    CSV Validation PlanTemplate (Summary Format) Section Description 1. Introduction Purpose, scope, and objectives of the validation plan 2. System Description Overview of the system (e.g., LIMS, MES, SCADA), including version and purpose 3. Scope of Validation Define modules/functions in scope (e.g., user management, reporting) 4. Risk Assessment GAMP 5-based risk assessment to determine validation depth 5. Validation Activities Lifecycle: URS → FS/DS → IQ → OQ → PQ → Release 6. Roles & Responsibilities QA, IT, Business Owner, Validation Lead – detailed RACI matrix 7. Deliverables Validation documents: protocol, scripts, traceability matrix, final report 8. Acceptance Criteria Clearly defined success criteria for each validation stage 9. Change Management Process for handling patches, updates, and system changes 10. Backup & Recovery Approach for ensuring data integrity and disaster recovery 11. Schedule Timeline of validation activities 12. Approval Signatures QA, System Owner, Validation Lead
  • 23.
    Traceability Matrix Template(CSV) URS ID Functional Requirement Test Case ID Test Description Test Result Remarks URS-01 User login must be secure TC-01 Verify password complexity rules Pass/Fail URS-02 Audit trail functionality TC-02 Check system logs for changes Pass/Fail
  • 24.
    GAMP 5 SystemCategory Classification Chart GAMP Category System Type Example Validation Focus Category 1 Infrastructure Software Operating systems, database engines Qualified as part of IT infrastructure Category 3 Non-configurable Commercial Software Office tools (e.g., Excel), browsers Document intended use Category 4 Configured Software LIMS, ERP (configured via settings, not coded) Configuration management & testing Category 5 Custom/Bespoke Software In-house developed or heavily customized systems Full validation, SDLC documentation
  • 25.
    Analytical Method Validation Confirmsthat analytical methods are suitable for their intended use in terms of accuracy, precision, specificity, and robustness. Analytical Method Validation (AMV) is a key component of the Validation Master Plan (VMP) in the pharmaceutical industry. It ensures that the analytical methods used for testing raw materials, intermediates, and finished products are scientifically sound, reproducible, and suitable for their intended purpose. Purpose of AMV in VMP •Confirm methods provide accurate, reliable, and consistent results. •Ensure compliance with regulatory expectations: • ICH Q2(R2) (newest) • USP <1225>, <1226> • EMA, FDA, WHO TRS
  • 26.
    Key Elements ofAnalytical Method Validation in VMP Section Description Objective Define the scope and goals of method validation within the quality framework. Scope Covers methods for identity, assay, impurities, content uniformity, etc. Regulatory References ICH Q2(R2), USP, EP, JP, FDA Guidance Types of Methods Chromatographic (HPLC, GC), spectroscopic (UV, IR), titrimetric, etc. Validation Parameters Based on method type: accuracy, precision, specificity, linearity, range, LOD/LOQ, robustness, system suitability Validation Protocols Pre-approved documents outlining objectives, test plan, criteria, responsibilities Acceptance Criteria Defined per parameter and method per ICH and pharmacopeial guidelines Revalidation Criteria When method changes occur (equipment, reagents, procedure) Documentation Method SOP, protocol, raw data, validation report, summary tables Roles & Responsibilities QC Lab, QA, Method Developer, Regulatory Affairs
  • 27.
    Typical Validation Parameters(ICH Q2) Parameter Applicable To Specificity All methods Linearity Quantitative methods Accuracy Quantitative methods Precision Repeatability and intermediate Detection Limit Impurities and limit tests Quantitation Limit Assay and impurity methods Robustness All methods System Suitability All methods with instrumentation
  • 28.
    Revalidation Performed when changesoccur or after a defined period to ensure continued compliance and performance. Revalidation ensures that validated systems, equipment, and processes remain in a state of control over time. It is a core element of the Validation Master Plan (VMP) to maintain compliance and product quality in pharmaceutical manufacturing. Purpose of Revalidation • To confirm that previously validated systems still meet predefined criteria. • Required when changes, deviations, or time-based intervals occur. • Ensures continued assurance of process performance and product quality.
  • 29.
    Types of Revalidation TypeTriggering Events Routine (Periodic) Time-based schedule (e.g., every 2–3 years), regardless of changes Change-Based After changes to equipment, process, utilities, software, or materials Deviation-Based Triggered by out-of-spec (OOS), out-of-trend (OOT), or critical deviations Product Discontinuation/Restart For systems not used over long periods and being reintroduced
  • 30.
    Scope of Revalidationin VMP Area Revalidation Requirement Facilities & HVAC Structural modifications, new installations Equipment Relocation, major maintenance, software upgrades Utilities (Water, Air, Steam) Changes to generation/distribution systems Process Major changes to critical parameters, raw materials, batch size Cleaning Procedures Detergent change, new contact surface, failure in cleaning verification Computer Systems Software version updates, configuration changes Analytical Methods Modified procedures, new instruments
  • 31.
    Key VMP DeliverablesRelated to Revalidation • Revalidation Schedule (calendar or tracker) • Change Control Records • Risk Assessment Reports • Revalidation Protocols & Reports • Deviation & Investigation Reports • Final Approval and QA Summary
  • 32.
    Change Control Change Controlis a formal system used to manage, document, and evaluate any changes that could impact the validated state of systems, processes, equipment, or facilities. It ensures product quality, safety, and regulatory compliance are maintained. Objective of Change Control in VMP To establish a structured process to: • Assess proposed changes. • Evaluate risks and impact. • Implement changes with necessary revalidation. • Maintain traceability and compliance.
  • 33.
    Key Elements ofChange Control in the VMP Component Description Scope Includes changes to equipment, processes, software, documents, and utilities Initiation Change is proposed and documented via a change control form (CCF) Impact Assessment Cross-functional risk evaluation (impact on quality, safety, validation status) Change Classification Minor, Major, or Critical (based on risk to validated state or compliance) Review & Approval QA, Validation, and Functional Owners must review and approve Implementati on Plan Includes actions, testing, training, and timelines Revalidation Decision Based on risk and impact; documented in the change control record Closure Verified post-implementation; QA confirms all actions completed
  • 34.
    Change Control Workflow(Typical) 1. Initiate Change ↓ 2. Impact Assessment (QA/Validation/Engineering) ↓ 3. Determine Revalidation Requirement ↓ 4. Approval by Responsible Departments ↓ 5. Implementation ↓ 6. Verification & Documentation ↓ 7. QA Review & Closure Documentation & Tools •Change Control Form (CCF) •Risk Assessment Template •Change Log •Revalidation Justification Report •Deviation Linking (if applicable)
  • 35.
    RiskAssessment in VMP RiskAssessment in the VMP provides a structured approach to identify, evaluate, and mitigate potential risks that may affect product quality, patient safety, and regulatory compliance during validation activities. Purpose of Risk Assessment in VMP •To apply science- and risk-based principles (aligned with ICH Q9). •To determine the scope and extent of validation activities. •To prioritize efforts based on risk level (High, Medium, Low). •To support change control, deviation, and revalidation decisions.
  • 36.
    When Is RiskAssessment Used in VMP? Validation Activity Risk Assessment Application Facility and Equipment Assess potential for contamination, downtime, or failures Process Validation Identify critical process parameters (CPPs) and their variability Cleaning Validation Evaluate residue risk and cleaning effectiveness Computer System Validation Classify systems based on GAMP 5 and impact on product quality Analytical Method Validation Determine criticality of method accuracy and precision Change Control & Revalidation Evaluate impact of changes on validated state
  • 37.
    Risk Assessment ToolsCommonly Used in VMP Tool Purpose FMEA Failure Modes and Effects Analysis – for equipment/process analysis Risk Ranking Matrix Classify risk based on severity, probability, detectability Impact Assessment Qualitative or quantitative analysis for changes Hazard Analysis For utilities, facility design, or critical systems Typical Risk Ranking Criteria Risk Factor Low (1) Medium (2) High (3) Severity Minor impact Moderate impact Major risk to product/patient Probability Rarely occurs Occasionally occurs Frequently occurs Detectability Easily detected Detected with effort Difficult to detect
  • 38.
    Validation Planning Validation Planningin a VMP outlines how validation activities will be structured, executed, and documented to ensure compliance with regulatory expectations (e.g., FDA, EMA, WHO). Key Components of Validation Planning in VMP Component Description Scope of Validation Defines systems, processes, and equipment included in the validation effort Validation Strategy Approach (e.g., prospective, concurrent, retrospective) based on risk Validation Schedule Timeline or Gantt chart outlining validation activities Resources Required Teams, departments, and third parties involved Documentation Plan Required protocols and reports (e.g., URS, DQ, IQ, OQ, PQ, summary reports) Roles & Responsibilities Assignment of responsibility for approvals, execution, review Acceptance Criteria Clear, measurable criteria to determine if validation is successful Deviation Management Procedures to handle unexpected results or deviations during validation
  • 39.
    Example: Validation Timeline MonthActivity Jan User Requirements Specification (URS) Feb–Mar Design Qualification (DQ), Installation Qualification (IQ) Apr–May Operational Qualification (OQ) Jun Performance Qualification (PQ) Jul Summary Report & Final Review
  • 40.
    Document Control Document Controlensures that all validation-related documents are properly created, reviewed, approved, issued, distributed, revised, and archived in a controlled manner. Purpose in VMP To maintain the integrity, traceability, and regulatory compliance of all documents generated during validation activities. Key Elements of Document Control Aspect Description Document Numbering Unique ID assigned to each validation document for traceability Version Control Tracks changes and maintains current approved versions Approval Process Review and sign-off by QA, Validation, and other stakeholders Distribution Ensures only the current version is available for use Archiving & Retention Secure storage and retrieval for a defined retention period Access Control Limits editing/approval rights to authorized personnel Change History (Audit Trail) Records all document modifications with date and responsible person
  • 41.
    Examples of ControlledDocuments •Validation Master Plan (VMP) •Validation Protocols (IQ, OQ, PQ) •Risk Assessments •Traceability Matrix •Deviation Reports •Summary Reports •SOPs related to validation Best Practices •Use a Document Management System (DMS) or Electronic Document Management System (EDMS). •Implement periodic reviews and revisions based on product lifecycle or regulatory updates. •Include a Document Control SOP in the VMP.
  • 42.
    Training Requirements ina Validation Master Plan Purpose of Training Requirements To ensure that all personnel involved in validation activities: •Understand their roles and responsibilities. •Possess adequate knowledge of GMP (Good Manufacturing Practice). •Are competent in using relevant equipment, procedures, and documentation practices. Who Needs to be Trained? • Validation team members • QA/QC personnel • Production and maintenance staff • Engineering teams • Data integrity and documentation personnel Types of Required Training • GMP & Regulatory Compliance Training • Validation Principles & Protocols (IQ, OQ, PQ) • Equipment Qualification Procedures • Cleaning Validation • Analytical Method Validation • Software/Computer System Validation • Deviation and Change Control Handling Training Methodologies • Classroom sessions • On-the-job training • SOP-based instructions • External workshops/seminars • E-learning modules (for periodic refreshers)
  • 43.
    Training Documentation •Training recordsmust be maintained as per GDP. •Each record should include: • Date of training • Trainer and trainee names • Content or SOPs covered • Evaluation results (if any) • Signatures for acknowledgment Evaluation of Training Effectiveness •Post-training assessments (quizzes or practical demos) •Supervisor observation and feedback •Periodic re-evaluation (e.g., annually) Retraining Triggers •SOP or regulatory changes •Equipment upgrades •After audits or non-compliance findings •Observed errors or incidents Responsibilities •QA Department: Ensures training needs are identified and met. •HR/Training Coordinator: Schedules and tracks training programs. •Supervisors: Ensure team participation and effectiveness. •Employees: Attend, understand, and implement training.
  • 44.
    Training Requirements –Summary Table for VMP Element Details Objective Ensure personnel are qualified to perform validation activities. Personnel to be Trained Validation team, QA/QC, production, engineering, maintenance, IT staff. Training Topics GMP, IQ/OQ/PQ, equipment qualification, cleaning validation, data integrity. Training Methods Classroom, on-the-job, SOP-based, e-learning, external workshops. Training Frequency Initial (induction), periodic (e.g., annually), as needed (SOP changes). Evaluation Methods Written tests, practical demonstrations, supervisor evaluations. Training Records Maintained as per GDP; includes date, content, signatures, evaluations. Retraining Triggers SOP changes, audit findings, incidents, equipment changes. Responsible Departments QA, HR/Training Coordinator, Supervisors.
  • 45.
    QualityAssurance Role –Summary Table QA Responsibility Details Review & Approve VMP, protocols (IQ/OQ/PQ), validation reports Compliance Oversight Ensures validation aligns with GMP and regulatory standards Documentation Control Manages SOPs, validation records, and training documents Deviation/CAPA Management Handles validation deviations and verifies effectiveness of CAPA Risk Assessment Participates in validation risk analysis and mitigation planning Training Verification Ensures all validation personnel are adequately trained Audit Participation Prepares for internal/external audits, addresses findings Continuous Improvement Suggests improvements in validation based on audit trends and feedback
  • 46.
    Monitoring and Review Objective: Toestablish a structured approach for continuous oversight and periodic evaluation of validation activities to ensure sustained compliance and effectiveness. Key Components 1. Routine Monitoring •Regular tracking of validation progress against the VMP schedule. •Monitoring of validation metrics like completion rates, deviations, CAPA closure, etc. •Evaluation of system performance post-validation to detect drift or non- conformance. 2. Review Frequency •Typically conducted quarterly or annually depending on the scope and risk. •Triggered by events such as: • Change controls • Deviations • Audit observations • Product quality complaints 3. Review Activities •Review of: • Completed validation protocols and reports • Open and overdue validation items • Deviations and CAPAs • Training records •Comparison with regulatory expectations and industry best practices. 4. Outcomes of Review •Identification of areas needing revalidation. •Recommendations for changes in procedures, training, or documentation. •Update or revision of the VMP if necessary. •Enhanced planning for future validations. 5. Roles and Responsibilities •QA Department: Leads the review, records findings, initiates necessary actions. •Validation Team: Provides documentation and evidence. •Management: Approves any VMP updates or resource reallocations.
  • 47.
    Monitoring and Review– Summary Table Aspect Details Purpose Ensure validation remains effective and compliant Frequency Quarterly, annually, or based on events (e.g., deviations, audits) What is Monitored? Validation timelines, deviations, CAPAs, performance, training, compliance Key Activities Document review, gap analysis, trend analysis, KPI tracking Responsible Parties QA (lead), validation team, management Outcomes Revalidation, updates to VMP, improved training or process controls
  • 48.
    Example: Equipment Validation ElementDetails Equipment Name Tablet Compression Machine (e.g., Rimek Mini Press-II) Equipment ID EQP-TCM-001 Location Manufacturing Area – Solid Dosage Section Validation Type Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ) Purpose of Validation To ensure the machine is installed, operates, and performs as per specifications IQ Activities Verify installation against design specs, utility connections, part list OQ Activities Test operational functions: RPM, compression force, safety interlocks PQ Activities Trial batch compression, evaluate tablet weight, hardness, thickness uniformity Acceptance Criteria Must meet predefined specs and tolerances during all qualification phases Responsibility Engineering, Production, and Quality Assurance Validation Status Completed / Scheduled / In Progress Revalidation Frequency Every 2 years or upon major change Reference Documents Equipment Manual, Calibration SOP, Validation Protocol
  • 49.
    Example: Process Validation– Summary Table Element Details Product Name Paracetamol 500 mg Tablets Batch No. for Validation PV001, PV002, PV003 (3 consecutive batches) Type of Validation Prospective Validation Purpose To establish documented evidence that the process is capable of producing acceptable product consistently Critical Process Steps Mixing, Granulation, Drying, Compression, Coating Critical Parameters Mixing time, granule moisture content, compression force, coating thickness Acceptance Criteria Must meet specifications for weight variation, hardness, friability, assay, dissolution Validation Activities Sampling at each stage, in-process testing, end-product testing Statistical Tools Standard deviation, RSD, process capability index (Cpk) Responsibilities Production (execution), QA (oversight & review), QC (testing) Documentation Process Validation Protocol, Batch Manufacturing Record (BMR), Validation Report Revalidation Criteria Process change, new equipment, failure investigation Status Completed / In Progress / Scheduled
  • 50.
    Example: Cleaning Validation– Summary Table Element Details Equipment Name Fluid Bed Dryer (FBD) Product Cleaned From Metformin Hydrochloride Tablets Next Product Paracetamol Tablets Cleaning Method Manual cleaning using water and approved detergent, followed by drying Type of Validation Prospective / Concurrent / Periodic Sampling Methods Swab sampling & Rinse sampling Acceptance Criteria <10 ppm product residue, <100 CFU/ml microbial count, no visible residue Worst Case Determination Based on product solubility, potency, batch size, difficulty to clean Analytical Method Used HPLC for residue analysis, Bioburden for microbial limits No. of Validation Runs 3 consecutive successful cleanings Locations Sampled Hard-to-clean surfaces: corners, joints, outlet chute, filter housing Documentation Cleaning Validation Protocol, Sample Plan, Test Results, Final Report Revalidation Criteria Change in cleaning procedure, new product introduction, equipment modification Status Completed / Scheduled / In Progress
  • 51.
    Deviation Management Objective ofDeviation Management in VMP: • To establish a standardized and systematic approach for identifying, documenting, evaluating, and resolving deviations encountered during validation activities. • To ensure that all deviations are managed in compliance with regulatory requirements and do not compromise product quality, safety, or efficacy. • To ensure that appropriate corrective and preventive actions (CAPA) are implemented and monitored effectively. Purpose of Deviation Management in VMP: • To maintain control over validation processes by effectively addressing deviations from approved procedures or specifications. • To ensure transparency and traceability in handling non-conformities during validation. • To enable root cause analysis and continuous improvement through proper investigation and trending of deviations. • To minimize the risk of product defects, regulatory non-compliance, and process variability due to unaddressed deviations.
  • 52.
    Deviation Management inValidation Master Plan (VMP) Aspect Description Definition A deviation is any departure from an approved process, instruction, or standard operating procedure (SOP) during validation. Purpose To ensure all deviations are properly identified, documented, investigated, and resolved to maintain product quality and compliance. Types of Deviations - Planned Deviation: Authorized change from a procedure with prior approval.- Unplanned Deviation: Unexpected departure during execution. Deviation Identification Any personnel involved in validation activities can report a deviation immediately upon noticing. Documentation All deviations must be recorded in a deviation report with detailed description, date/time, location, and responsible personnel. Investigation Process Root cause analysis (RCA) conducted to determine underlying cause(s). Tools: 5 Whys, Fishbone Diagram, etc. Impact Assessment Evaluate deviation impact on:- Product quality- Validation outcome- Regulatory compliance Corrective & Preventive Actions (CAPA) - Corrective Action: Fix the issue.- Preventive Action: Prevent recurrence. Approval & Closure QA/Validation Head reviews and approves closure of the deviation after CAPA implementation. Revalidation Trigger Significant deviations may trigger full or partial revalidation depending on the severity and impact. Trending & Monitoring Periodic review of deviation data to identify trends or repeated issues, improving future processes.
  • 53.
    Validation Report Objective ofValidation Report in VMP: •To formally document and summarize the outcome of a validation activity. •To verify that all validation steps were completed according to the protocol and met pre- defined acceptance criteria. •To ensure that the validated process, equipment, or system performs consistently and reproducibly within established specifications. Purpose of Validation Report in VMP: •To provide documented evidence that the system or process meets its intended use and regulatory requirements. •To serve as a comprehensive record for internal audits and external inspections. •To support decisions regarding the approval, continuation, or revalidation of equipment, processes, or systems. •To include deviations, investigations, CAPAs, and conclusions related to the validation exercise.
  • 54.
    Validation Report inVMP – Summary Table Section Description Objective Summarizes the purpose and scope of the validation study System/Process Validated Name and description of the system, equipment, process, or method validated Validation Type Type of validation (e.g., Installation, Operational, Performance, Cleaning) Protocol Reference Identification number and title of the validation protocol used Execution Summary Summary of test execution, including dates and involved personnel Results Summary Overview of test results: passed/failed with justification Deviations Description of any deviations encountered and corrective actions taken Acceptance Criteria Whether acceptance criteria were met Conclusions Final conclusion about the state of validation (e.g., successful/failed) Recommendations Any recommendations for re-validation, preventive actions, or improvements Approval Signatures QA, validation, and relevant department heads approval with date
  • 55.
    Auditing and Inspections Ina Validation Master Plan (VMP), the "Auditing and Inspections" section outlines how validation processes are monitored and evaluated for compliance. Here's a structured summary table: Element Description Objective To verify that validation activities comply with internal procedures and regulations Types of Audits Internal audits, external audits, vendor audits, regulatory inspections Audit Frequency Defined periodicity (e.g., annual, biannual) depending on system/process criticality Responsible Department Quality Assurance (QA) or Compliance department Audit Scope Includes validation protocols, reports, data integrity, equipment logs, etc. Inspection Readiness Ensures all documentation is complete, traceable, and readily available Follow-Up and CAPA Corrective and Preventive Actions to address audit findings Documentation Audit reports, checklists, compliance certificates Regulatory Bodies Involved Examples: FDA, EMA, WHO, local health authorities Review and Approval Validation and QA management must review and approve audit findings Auditing and Inspections in VMP – Summary Table
  • 56.
    Common VMPMistakes Mistake DescriptionImpact 1. Vague Objectives Lack of clear scope or purpose of the validation activities Leads to confusion and inconsistent implementation 2. Incomplete System Inventory Missing list of all systems/equipment/processes to be validated Critical systems may be excluded from validation 3. Poor Risk Assessment No or inadequate risk-based approach to validation priorities Resources are misallocated; non- critical systems overemphasized 4. Lack of Traceability Missing links between user requirements, test cases, and results Compromises compliance and audit readiness 5. Undefined Roles & Responsibilities No clarity on who does what in validation Causes delays, accountability issues, and poor execution 6. Outdated References Use of obsolete standards (e.g., old GAMP or ICH guidelines) Regulatory non-compliance 7. Weak Change Control Integration Change control not tied into the validation lifecycle Unauthorized changes can go unvalidated 8. Inconsistent Documentation Practices Inadequate version control, unsigned documents, or missing approvals Leads to audit findings and poor data integrity 9. Missing Revalidation Criteria No guidance on when to revalidate after changes or time periods May result in operating non- compliant systems 10. Poor Review & Approval Process VMP not formally reviewed or approved by QA and management Lack of ownership and oversight
  • 57.
    Best Practices ina Master Validation Plan (VMP) Category Best Practice Why It Matters 1. Clear Scope & Objectives Clearly define what systems, equipment, and processes are covered. Helps align stakeholders and avoid scope creep. 2. Risk-Based Approach Prioritize validation activities based on risk to product quality and patient safety (aligned with ICH Q9 or GAMP 5). Focuses resources where they matter most. 3. Comprehensive System Inventory Include a validated system inventory with classification (e.g., GAMP categories). Ensures no critical system is overlooked. 4. Defined Roles & Responsibilities Assign QA, validation, engineering, and IT responsibilities in the MVP. Enables accountability and smooth execution. 5. Document Traceability Link user requirements → protocols → test results → final reports. Provides audit-ready traceability. 6. Integrated Change Control Tie validation requirements into the Change Control process. Ensures validated state is maintained post-change. 7. Lifecycle-Based Planning Cover Installation, Operational, and Performance Qualification (IQ/OQ/PQ). Ensures complete validation lifecycle. 8. Qualification Strategy Define qualification strategies for equipment, utilities, software, etc. Promotes consistent and efficient execution. 9. Revalidation Strategy Include periodic review, triggers, and criteria for revalidation. Keeps systems compliant over time. 10. Audit Preparedness Ensure the MVP is regularly reviewed, up- to-date, and aligned with current regulatory expectations. Minimizes audit risks.
  • 58.
    CommonAnnexures in aVMP Annexure No. Title Description Annexure I Validation Inventory List Complete list of systems, equipment, utilities, and processes requiring validation. Often categorized by type (e.g., GMP-critical vs. non-critical). Annexure II Validation Schedule Timeline or Gantt chart showing planned validation activities and milestones. Annexure III System Classification (e.g., GAMP Category) Classification of computerized systems according to GAMP 5 categories (e.g., Category 3, 4, 5). Annexure IV Risk Assessment Summary Output of risk assessments used to prioritize validation efforts. May include tools like FMEA or Risk Ranking. Annexure V Validation Document Matrix A traceability matrix linking URS, DQ, IQ, OQ, PQ, test cases, and reports. Annexure VI Change Control Log Historical record of changes affecting validated systems or processes. Annexure VII Training Records Evidence that validation team members are trained and qualified. Annexure VIII Vendor Qualification Records Includes audit reports or questionnaires for critical suppliers or service providers. Annexure IX Revalidation Criteria Lists conditions that trigger revalidation, including periodic review intervals. Annexure X Glossary of Terms & Abbreviations Ensures clarity of technical and regulatory language. Annexure XI List of Referenced SOPs/Documents Includes SOPs, guidelines, or external standards referenced in the VMP. Annexure XII Audit and Inspection Findings Summary Documents past audit observations and related CAPA linked to validation.
  • 59.
    Regulatory Updates The RegulatoryUpdates section of a VMP ensures that the validation strategy remains aligned with current regulatory expectations, guidance, and industry best practices. This is critical for maintaining compliance during inspections and audits. Purpose of Including Regulatory Updates in VMP •Demonstrate awareness and integration of current regulations and guidance. •Ensure that validation activities reflect up-to-date regulatory requirements. •Support risk-based approaches by linking them to the latest industry standards. Best Practices •Review and update this section annually or upon major regulatory changes. •Link updates directly to validation SOPs or change controls. •Maintain a Regulatory Change Log as an annexure.
  • 60.
    Component Details Title RegulatoryLandscape and Updates Objective Outline the framework of applicable regulatory guidelines and any recent updates impacting validation. Sources List of reference documents from:– FDA (e.g., 21 CFR Part 11, Part 210/211)– EU Annex 15– ICH Guidelines (e.g., Q8, Q9, Q10)– WHO, PIC/S, ISPE, GAMP 5– Local health authorities Recent Changes Summary of recent or significant regulatory changes (e.g., new FDA guidance on Computer Software Assurance, updated EU GMP Annexes) Impact on Validation Describe how updates affect:– Validation lifecycle– Documentation– Risk assessment– Frequency of revalidation– Data integrity requirements Action Plan List of changes made or planned in the VMP or validation strategy to address these updates. What to Include in the Regulatory Updates Section
  • 61.
    Case Study: FDA483 Due to Poor Validation Company Profile: •Type: Pharmaceutical Manufacturer (Sterile injectables) •Location: U.S.-based facility •Inspection Year: 2022 •Regulatory Body: U.S. FDA Observation from FDA 483: "Your firm failed to adequately validate the sterilization process used for drug product manufacturing. Specifically, your media fill simulations lacked proper documentation, acceptance criteria, and requalification strategy." Key Validation Failures Identified: Area Issue Process Validation Media fill protocols did not match commercial manufacturing conditions. No documented rationale for frequency or sampling plan. Revalidation No periodic revalidation schedule for critical aseptic processes. Data Integrity Media fill results were missing batch records and lacked real-time entry controls. Change Control Changes in sterilization cycle parameters were implemented without impact assessment or revalidation. Training Operators conducting validation were not documented as trained on revised SOPs.
  • 62.
    Consequences: •FDA issued Form483 with multiple observations. •Follow-up Warning Letter within 3 months due to repeat observations. •Firm had to initiate a product recall and suspend production. •Costly remediation: external consultants, revalidation of all aseptic processes, retraining of staff. Lessons Learned & Preventive Actions: Lesson Corrective Action (CAPA) Incomplete validation protocols Implement a protocol template checklist; QA to review all validation protocols pre-approval. Lack of periodic revalidation Add automated revalidation triggers to the change control system and annual validation calendar. Poor documentation Adopt an electronic document management system (EDMS) for version control and audit trails. Unqualified personnel Require documented training before involvement in validation activities. Non-compliant change control Integrate QA review of all changes impacting validated systems.
  • 63.
    How to ApplyThis in VMP: •Include a section: "Case Studies and Industry Learnings" •Add a risk mitigation strategy aligned with these learnings •Tie in CAPAs with your validation SOPs, training programs, and change control procedures
  • 64.
    Key Benefits ofa Robust VMP Benefit Why It Matters 1. Regulatory Compliance Ensures all validation activities comply with FDA, EMA, WHO, MHRA, and other regulatory bodies. Prevents 483s, warning letters, and product recalls. 2. Risk Management Supports a systematic, risk-based approach (e.g., ICH Q9, GAMP 5) that focuses resources on critical systems and processes. 3. Consistency & Standardization Establishes uniform procedures and documentation practices across all departments and facilities. 4. Improved Audit Readiness Demonstrates control and traceability of validation lifecycle, making inspections more manageable and less stressful. 5. Enhanced Quality Assurance Provides evidence that equipment, systems, and processes consistently perform as intended, protecting product quality and patient safety. 6. Efficient Change Control Integrates validation into the change management process, ensuring revalidation when needed and preventing unintended compliance gaps. 7. Better Resource Planning Allows scheduling of validation activities, avoiding overlaps, downtime, and resource conflicts. 8. Clear Roles & Responsibilities Clearly defines team responsibilities, improving accountability and communication. 9. Continuous Improvement Promotes regular review and updating of validation activities based on trends, CAPAs, and regulatory changes. 10. Cost Reduction Over Time Prevents expensive remediation, product failures, and rework by getting validation right the first time.
  • 65.
    Conclusion The Validation MasterPlan (VMP) is a critical, high-level document that outlines a company's overall strategy and approach to validation across systems, equipment, facilities, utilities, processes, and computer systems. A well-structured VMP ensures that all validation activities are planned, executed, and documented in a consistent, risk-based, and compliant manner. Key Takeaways: • The VMP serves as a roadmap for ensuring that systems and processes meet regulatory requirements (e.g., FDA, EMA, WHO). • It defines validation objectives, scope, responsibilities, documentation requirements, revalidation triggers, and risk management strategies. • Proper implementation of the VMP ensures data integrity, product quality, and patient safety. • Integration of GAMP 5, ICH guidelines, and change control mechanisms enhances the robustness of the validation framework. • Regular review and updates of the VMP keep the organization aligned with current regulatory expectations and industry best practices. “A robust VMP is not just a regulatory requirement — it is a cornerstone of a company’s quality and compliance strategy.”
  • 66.
    Thank You! Thank youfor your attention and commitment to quality and compliance. A well-executed VMP not only fulfills regulatory requirements but lays the foundation for operational excellence and patient safety. "Validation is not a one-time task — it’s a culture of accountability. A strong VMP transforms compliance from a checkbox into a commitment." — Quality Assurance Principle